“Long‐term efficacy and safety of L‐glutamine in preventing sickle cell disease‐related acute complications and hemolysis in pediatric and adult patients—Real‐world, observational study”

Author:

Elenga Narcisse1ORCID,Loko Gylna2ORCID,Etienne‐Julan Maryse3ORCID,Al‐Okka Randa4,Adel Ahmad M.4ORCID,Yassin Mohamed A.5ORCID

Affiliation:

1. Centre Hospitalier de Cayenne Cayenne France

2. Centre de reference de la drepanocytose, CHU de la Guadeloupe Pointe‐à Pitre Guadeloupe France

3. Centre de reference de la drepanocytose CH de Fort de France Fort‐de‐France France

4. Department of Pharmacy, NCCCR Pharmacy Hamad Medical Corporation Doha Ad Dawhah Qatar

5. Medical Oncology Department—Hematology Section, National Centre for Cancer Care and Research Hamad Medical Corporation Doha Ad Dawhah Qatar

Publisher

Wiley

Subject

Hematology,General Medicine

Reference5 articles.

1. A Phase 3 Trial ofl-Glutamine in Sickle Cell Disease

2. Real‐world data on efficacy of L‐glutamine in preventing sickle cell disease‐related complications in pediatric and adult patients;Narcisse Elenga GL;Front Med,2022

3. Sickle cell disease complications: Prevalence and resource utilization

4. Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3